h
Let’s Work Together
arrosa@select.com

Meet Arrosa, the perfect theme to elevate your online presentation with.

Search here!
Gorka Orive

Gorka Orive

PhD in Farmacia

Professore ordinario UPV/EHU. Ricercatore e Professore presso l’Istituto Universitario di Medicina Rigenerativa e Implantologia Orale UIRMI.

Laurea in Farmacia presso l’Università dei Paesi Baschi UPV / EHU (1999).

Dottorato di ricerca in Farmacia presso l’UPV / EHU (2003), entrambi con un premio straordinario.

Master in Sviluppo Farmacologico, Valutazione e Uso Razionale dei Farmaci presso l’UPV / EHU.

Master in Terapie Avanzate presso l’Università di Oviedo.

Professore e ricercatore presso l’Istituto Universitario di Medicina Rigenerativa e Implantologia Orale -UIRMI (Vitoria).

Professore presso l’UPV / EHU dal 2002.

Coautore di numerose pubblicazioni internazionali.

Articoli pubblicati

The increasing prevalence of tissue injuries is fueling the development of autologous biological treatments for regenerative medicine. Here, we investigated the potential of three different bioinks based on the combination of gelatin and alginate (GA), enriched in either hydroxyapatite (GAHA) or hydroxyapatite and PRGF (GAHAP), as a favorable microenvironment for human dental pulp stem cells (DPSCs)

  • Autore:
  • Eduardo Anitua
  • Gorka Orive
  • Miriam Idoipe
  • Borja de la Sen-Corcuera
  • Ronald M Sánchez-Ávila
  • Carmen Sánchez-Pérez
  • María Satué
  • Antonio Sánchez-Pérez
  • Francisco Muruzabal
  • Luis Pablo

This prospective and comparative study aimed to compare the use of a conjunctival autograft (CAG), plasma rich in growth factors fibrin membrane (mPRGF) or amniotic membrane transplantation (AMT) in primary pterygium surgery.

  • Autore:
  • Eduardo Anitua
  • Gorka Orive
  • Alfonso L Sabater
  • Hazem M Mousa
  • Xavier Quinones
  • Felipe Valenzuela
  • Ronald Mauricio Sanchez Avila
  • Jesús Merayo
  • Victor L Perez

To evaluate the safety and efficacy of the surgical use of autologous plasma rich in growth factors fibrin membrane (mPRGF) in improving corneal wound healing and regeneration in a variety of complex ocular surface defects.